The 2021 Diabetes Prevention Program trial, a placebo-controlled study of over 3,000 adults at high risk of type 2 diabetes over 21 years, found that metformin did not improve death rates, cancer, or cardiovascular disease, showing that human research does not support metformin for non-diabetics.
factualpending
Evidence Quote
“in 2021 a massive study was published by the diabetes prevention program involving over 3 000 adults at high risk of type 2 diabetes it was a placebo-controlled study over a 21-year period and compared with Evo metformin did not improve death rates cancer or cardiovascular disease”
Created: 8/10/2026, 9:22:16 PM
Your notes
Loading notes...